Skip to main content

Table 2 Pathway enrichment analysis items of 16 LRGs from KEGG

From: Identification of a novel lipid metabolism-related gene signature within the tumour immune microenvironment for breast cancer

ONTOLOGY ID Description GeneRatio BgRatio P value P.adjust qvalue
BP GO:0006641 triglyceride metabolic process 10/11 105/18670 2.23e-22 9.62e-20 5.50e-20
BP GO:0006639 acylglycerol metabolic process 10/11 129/18670 1.90e-21 2.96e-19 1.69e-19
BP GO:0006638 neutral lipid metabolic process 10/11 130/18670 2.06e-21 2.96e-19 1.69e-19
BP GO:0019433 triglyceride catabolic process 8/11 35/18670 1.06e-20 1.14e-18 6.52e-19
BP GO:0046461 neutral lipid catabolic process 8/11 43/18670 6.51e-20 4.68e-18 2.67e-18
MF GO:0005504 fatty acid binding 5/11 34/17697 8.82e-12 3.53e-10 1.30e-10
MF GO:0033293 monocarboxylic acid binding 5/11 64/17697 2.40e-10 4.79e-09 1.77e-09
MF GO:0005324 long-chain fatty acid transporter activity 3/11 11/17697 2.94e-08 3.92e-07 1.44e-07
MF GO:0031406 carboxylic acid binding 5/11 193/17697 6.42e-08 5.18e-07 1.91e-07
MF GO:0036041 long-chain fatty acid binding 3/11 14/17697 6.48e-08 5.18e-07 1.91e-07
KEGG hsa03320 PPAR signaling pathway 6/9 78/8076 5.48e-11 1.70e-09 1.50e-09
KEGG hsa04975 Fat digestion and absorption 2/9 43/8076 9.74e-04 0.015 0.013
KEGG hsa00561 Glycerolipid metabolism 2/9 61/8076 0.002 0.020 0.018
KEGG hsa00564 Glycerophospholipid metabolism 2/9 98/8076 0.005 0.038 0.034
KEGG hsa04150 mTOR signaling pathway 2/9 155/8076 0.012 0.075 0.066